271 assets in Renal Cell Carcinoma

Hydromorphon

Marcaine

Memantine

Naptumomab Estafenatox

Nepenthe

NKT2152

Oxaliplatin

Tiragolumab

Zirconium Zr 89 Girentuximab Deferoxamine

Avelumab

Tislelizumab

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

mk-2206

Sitravatinib

[18F]F-RESCA-R8B4

[18F]F-RESCA-RCCB6

[18F]F-RESCA-RD06

[68ga]ga-nota-r8b4

[68ga]ga-nota-rd06

Akkermansia Muciniphila

al8326

aur109

Autologous Alpha-Dc1/Tbva Vaccine

Balstilimab

Benmelstobart

Botensilimab

Ceralasertib

Empagliflozin

Evolocumab

Fianlimab

Finerenone

hb0025

ibi363

ibr854

Ibuprofen

Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide

Ivocizumab

Ivuxolimab

Lomustine

Oxycodone

Pamiparib

Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta

Serplulimab

Spartalizumab

Sturlimogene Erparepvec

Tuvonralimab

Urea

Wgi-0301

Yivoximab

3-(2,2,2-TRIMETHYLDIAZANIUMYL)PROPANOATE